The label notes, In Zepbound clinical trials, hair loss was reported more frequently in female than male patients in the Zepbound (7.1% female versus 0.5% male) and placebo (1.3% female versus 0% male) treatment groups. Treatments for hair loss Experts say telogen effluvium with GLP-1 use is typically temporary, but people who develop hair loss should seek medical evaluation
Research published in the "Journal of Nutritional Biochemistry" highlighted L-Carnitines ability to reduce oxidative damage in cells, contributing to improved cellular health and longevity
[3] Whether supraphysiological thiol levels compete for those transporters is unknown
Available data indicate that SGLT2-i cause plasma renin activity (PRA) increase in the early phase of treatment, while PRA and aldosterone levels remain unchanged in chronic treated patients
Abbreviations: GLP-1 RA = glucagon-like peptide-1 receptor agonist
By replenishing essential nutrients directly into the bloodstream, IV therapy supports various bodily functions, aiding in recovery and overall well-being